Table of Contents Table of Contents
Previous Page  226 / 258 Next Page
Information
Show Menu
Previous Page 226 / 258 Next Page
Page Background

C

ampos

G

iménez

&

M

artin

:

J

ournal of

AOAC I

nternational

V

ol

.

100, N

o

.

1, 2017 

143

the SMPR. Repeatability decreased from 31.8% in the part 2

to 1.5%, whereas reproducibility decreased from 33.0 to 6.5%;

both values well below requirements. For infant formula RTF

(milk-based), despite improved precision numbers (repeatability

went from 25.6 to 10.7%, whereas reproducibility went from

30.6 to 13.2%), these values remained outside of the SMPR.

The hypothesis that either sample spoilage (presumably of the

RTF) or can mislabeling (most likely the powder) took place

during the first round seemed to be confirmed.

One of the participants decided to analyze the four bottles

received in duplicate. To mirror this experiment, the decision

was made to also analyze the samples at the Nestlé Research

Center using a different method (AOAC

Official Method

SM

985.33

). Both sets of data (data not shown) confirmed that

the variability observed in the RTF sample came from sample

heterogeneity not the method. These data were presented to the

ERP in March 2016 and subsequently accepted.

Conclusions

The precision figures obtained during this collaborative study

show that Method

2012.22

complies with the requirements

set in the corresponding SMPR, and thus, that the method is

fit for purpose for the analysis of vitamin C (

l

-ascorbic acid)

in infant formula and adult/pediatric nutritionals. Both HPLC

(5) or UHPLC (6) conditions are of equivalent performance,

provided that suitability conditions are respected, thereby

allowing for method applicability in all laboratories. These data

were submitted to the ERP for review at the Mid-Year AOAC

Meeting annual meeting held in March 2016 in Gaithersburg,

MD. The ERP determined that the presented data met the SMPR

set by SPIFAN, and thus recommended the method be granted

Final Action status.

Acknowledgments

We especially thank Colleen Fehrenbach at Covance

Laboratories (Madison, WI) for dispatching samples to the

participants. We greatly thank the following participants

and their associates for their valuable contributions to the

study: Karen Schimpf and Linda Butler Thompson, Abbott

Laboratories (Columbus, OH); Dalal Aoude-Werner and Julie

Dalmas-Le Grandois, Aérial (Illkirch, France); Jeanette Wong

and Joanne Chia, ALS Global (Singapore); Isabelle Malaviole,

Laboratoire Aquanal (Pessac, France); Maggie Mapar, Tiffany

Nguyen, and Michael Hoard, Arizona Nutritional Supplements

(Chandler, AZ); George Joseph, Asure Quality (Auckland, New

Zealand); Lifu Ma, Certified Laboratories (Plainview, NY);

Bolong Wu, Chinese Academy of Inspection and Quarantine

(Beijing, People’s Republic of China); Tom Rogers and John

Austad, Covance Laboratories (Madison, WI); Bente Marianne

Jensen, Ina Pedersen, and Sabine Meng Jensen, Eurofins Steins

Laboratorium A/S (Vejen, Denmark); Yinghui Zhang and

Wenjuan Jobgen, Eurofins Scientific, Inc. (Des Moines, IA);

Table 2. Results of statistical analysis on original set of data

a

SMPR 2012.012

requirements

n

b

Avg.,

mg/100 g

≤5% ≤10%

HorRat

RSD

r

, % RSD

R

, %

Adult nutritional

RTF (high-fat)

c

21

17.6

4.2

11.3

1.5

SRM 1849a

d

17

8.1

3.5

3.7

0.5

Child formula

powder

19

4.9

2.6

4.5

0.5

Adult nutritional

powder (milk

protein-based)

19

6.3

1.4

3.2

0.4

Infant formula

powder

(soy-based)

17

10.3

1.6

6.0

0.8

Infant formula RTF

(milk-based)

19

3.5

25.6

e

30.6

e

3.3

e

Adult nutritional

powder (low-fat)

21

11.0

31.8

e

33.0

e

4.2

e

Adult nutritional

RTF (high-protein)

18

19.7

1.7

9.3

1.3

Infant elemental

powder

21

34.0

7.3

11.4

1.7

Infant formula

powder (partially

hydrolyzed,

soy-based)

22

19.5

2.4

8.0

1.1

a

 Average, RSD

r

, RSD

R

, and HorRat values after removal of outliers.

b

n

represents the number of laboratories considered in the evaluation

(after removal of outliers). Twenty-two laboratories reported data.

c

 RTF=Ready-to-feed.

d

 SRM=Standard Reference Material.

e

 Results suspected to be related to sample integrity.

See

Table 4 for

the final reproducibility results on these two matrixes.

Table 3. Full set of additional data on matrixes suspected

to be spoiled (liquid) or mislabeled (powder) in the original

testing

a

Lab

No.

Infant formula RTF

(milk-based)

b

Adult nutritional

powder (low-fat)

1

17.5

18.0

13.1

13.0

2

20.0

20.1

12.9

12.2

3

18.2

18.0

11.7

14.1

4

17.7

17.6

12.5

10.9

5

17.5

17.3

13.2

12.0

6

18.0

17.7

12.7

15.0

7

16.0

15.3

13.8

9.8

8

16.4

17.0

11.5

10.5

9

17.1

17.5

10.7

11.0

10

17.8

17.9

9.0

9.8

a

 All results are in mg/100 g of reconstituted powder (25 g+200 g water)

or are as-is for RTF.

b

 RTF=Ready-to-feed.

Table 4. Results of statistical analysis of the additional set

of data: average, RSD

r

, RSD

R

, and HorRat values

SMPR 2012.012

requirements

n

a

Avg.,

mg/100 g

≤5% ≤10%

RSD

r

, % RSD

R

, % HorRat

Infant formula RTF

(milk-based)

b

10

12.0 10.7 13.2

1.7

Adult nutritional

powder (low-fat)

10

17.6

1.5

6.5

0.9

a

 n

represents the number of laboratories in the evaluation. No outliers

were removed.

b

RTF=Ready-to-feed.

226